Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzhexol adverse reaction (disorder) |
Causative agent (attribute) |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzhexol 2mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzhexol hydrochloride 5mg/5mL syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trihexyphenidyl hydrochloride 5mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trihexyphenidyl hydrochloride 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trihexyphenidyl hydrochloride 5mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trihexy-2 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trihexyphenidyl hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Trihexyphenidyl hydrochloride 5mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzhexol 2mg/5mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Trihexyphenidyl hydrochloride 1 mg/mL oral solution |
Has precise active ingredient |
True |
Trihexyphenidyl hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |